Bibliographic Details
| Title: |
The development of potent and selective bisarylmaleimide GSK3 inhibitors. |
| Authors: |
Engler TA; Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. engler_thomas@lilly.com, Malhotra S, Burkholder TP, Henry JR, Mendel D, Porter WJ, Furness K, Diefenbacher C, Marquart A, Reel JK, Li Y, Clayton J, Cunningham B, McLean J, O'toole JC, Brozinick J, Hawkins E, Misener E, Briere D, Brier RA, Wagner JR, Campbell RM, Anderson BD, Vaughn R, Bennett DB, Meier TI, Cook JA |
| Source: |
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2005 Feb 15; Vol. 15 (4), pp. 899-903. |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print Cited Medium: Print ISSN: 0960-894X (Print) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
